Vanguard Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Vanguard Capital Management's UTHR Position: Q3 2026 in Review
Vanguard Capital Management increased its United Therapeutics (UTHR) stake by 0.56% in Q3 2026, buying an estimated $5.52M and bringing the position to 1,928,928 shares worth $1.05B. The position accounts for 0.02% of the portfolio, ranked #472.
Vanguard Capital Management first reported a position in UTHR in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.16B in Q1 2026. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Vanguard Capital Management held 1,928,928 shares of United Therapeutics worth $1.05B as of Q3 2026.
- Vanguard Capital Management bought 10,672 United Therapeutics shares in Q3 2026, an estimated $5.52M.
- United Therapeutics made up 0.02% of Vanguard Capital Management's portfolio in Q3 2026, its #472 holding.
- Vanguard Capital Management first reported a position in United Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's United Therapeutics position peaked at $1.16B in Q1 2026.
- 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.